We are live on ! Find out more
TAM

Tiverton Asset Management Portfolio holdings

AUM $2.88B
1-Year Est. Return 5.6%
This Fund
S&P 500
This Quarter Est. Return
+16.23%
1 Year Est. Return
+5.6%
3 Year Est. Return
+61.83%
5 Year Est. Return
+105.31%
10 Year Est. Return
–
AUM
$2.31B
AUM Growth
+$641M
Cap. Flow
+$372M
Cap. Flow %
16.15%
Top 10 Hldgs %
31.4%
Holding
680
New
190
Increased
323
Reduced
69
Closed
28

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$9.6M
2
AOS icon
A.O. Smith
AOS
+$7.79M
3
JPM icon
JPMorgan Chase
JPM
+$7.71M
4
MSFT icon
Microsoft
MSFT
+$6.58M
5
BAC icon
Bank of America
BAC
+$6.05M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$7.15M
2
MD icon
Pediatrix Medical
MD
+$3.07M
3
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$2.05M
4
W icon
Wayfair
W
+$1.83M
5
ARWR icon
Arrowhead Research
ARWR
+$1.69M

Sector Composition

Rank Sector Weight
1 Technology 19.35%
2 Healthcare 15.48%
3 Consumer Discretionary 11.83%
4 Financials 11.36%
5 Communication Services 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTE
651
DELISTED
PolarityTE, Inc. Common Stock
PTE
$10K ﹤0.01%
36
– –
FHB icon
652
First Hawaiian
FHB
$3.35B
$3K ﹤0.01%
+100
New +$2.59K
APLS
653
DELISTED
Apellis Pharmaceuticals
APLS
– –
-8,238
Closed -$108K
ARVN icon
654
Arvinas
ARVN
$572M
– –
-933
Closed -$12K
BMY icon
655
Bristol-Myers Squibb
BMY
$132B
– –
-20,596
Closed -$1.07M
CMA
656
DELISTED
Comerica
CMA
– –
-2,939
Closed -$202K
DVA icon
657
DaVita
DVA
$11.7B
– –
-847
Closed -$44K
KMI icon
658
Kinder Morgan
KMI
$68.7B
– –
-37,144
Closed -$571K
LEG icon
659
Leggett & Platt
LEG
$1.31B
– –
-10,380
Closed -$372K
PCG icon
660
PG&E
PCG
$38.5B
– –
-1,658
Closed -$39K
PTGX icon
661
Protagonist Therapeutics
PTGX
$9.44B
– –
-2,193
Closed -$15K
SGMO
662
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
– –
-85,781
Closed -$984K
SLDB icon
663
Solid Biosciences
SLDB
$900M
– –
-348
Closed -$140K
SRRK icon
664
Scholar Rock
SRRK
$6.44B
– –
-651
Closed -$15K
TARA icon
665
Protara Therapeutics
TARA
$232M
– –
-325
Closed -$30K
TBI
666
Trueblue
TBI
$311M
– –
-29,154
Closed -$649K
TPST icon
667
Tempest Therapeutics
TPST
$14.6M
– –
-8
Closed -$13K
EIGR
668
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
– –
-31
Closed -$10K
MMP
669
DELISTED
Magellan Midstream Partners, L.P.
MMP
– –
-8,241
Closed -$470K
PRTK
670
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
– –
-5,756
Closed -$30K
IMMU
671
DELISTED
Immunomedics Inc
IMMU
– –
-9,795
Closed -$140K
RST
672
DELISTED
ROSETTA STONE INC
RST
– –
-23,970
Closed -$393K
AIMT
673
DELISTED
Aimmune Therapeutics
AIMT
– –
-3,772
Closed -$90K
SNNA
674
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
– –
-17,364
Closed -$40K
WP
675
DELISTED
Worldpay, Inc.
WP
– –
-2,510
Closed -$192K
24 25 26
27
28

Similar funds

TAM
Tyers Asset Management Austin, Texas $3.02B AUM 5.29% 1-Year Est. Return
RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return
NA
Neuburgh Advisers Los Angeles, California $3.22B AUM 3.74% 1-Year Est. Return
FCM
Flinton Capital Management Philadelphia, Pennsylvania $3.22B AUM 4.75% 1-Year Est. Return
STMM
South Texas Money Management San Antonio, Texas $2.37B AUM 5.24% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
CA
Cortland Advisers Wilmington, Delaware $2.18B AUM 8.82% 1-Year Est. Return
BA
Boston Advisors Boston, Massachusetts $1.91B AUM 6.26% 1-Year Est. Return

Tiverton Asset Management's Q1 2019 Portfolio in Review

As of Q1 2019, Tiverton Asset Management held 680 positions worth $2.31B, up 38% from $1.66B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Tiverton Asset Management deployed $372M of net new capital in Q1 2019, opening 190 new positions and adding to 323 existing holdings. Its largest new stake was Pfizer: 104,318 shares worth $4.2M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Celgene Corp, an estimated $7.15M trimmed.

  • Tiverton Asset Management's largest Q1 2019 buy was Pfizer: 104,318 shares worth $4.2M.
  • Tiverton Asset Management added most to Alphabet (Google) Class A in Q1 2019, an estimated $9.6M increase.
  • Tiverton Asset Management's biggest Q1 2019 reduction was Celgene Corp, cutting an estimated $7.15M.
  • Tiverton Asset Management fully exited Bristol-Myers Squibb in Q1 2019, selling an estimated $1.07M.
  • Tiverton Asset Management's ten largest holdings make up 31% of its $2.31B portfolio in Q1 2019.
  • Tiverton Asset Management opened 190 new positions and closed 28 in Q1 2019.
  • Tiverton Asset Management's portfolio value rose 38% quarter-over-quarter to $2.31B.

Based on Tiverton Asset Management's 13F filing for Q1 2019, filed 13 May 2019.